Ruohan Chen

Jun 26, 2024 | journalofinfection.com | Zhanwei Du |Shuqi Wang |Ruohan Chen |Songwei Shan

Note, the values and 95% confidence interval for the efficacy of RSV vaccines against RSV infection/illness were summarized in this table. #The CI of the efficacy results are for 96.5% Confidential Interval. &The CI of the efficacy results are for 96.66% Confidential Interval. a Young and middle-aged adults aged 18-50. b Older adults, could be aged 60 or older or 65 or older in different studies. c RSV-related lower respiratory tract disease (RSV LRTD) were identified by the adjudication committee.